SEC Tracker
Get the app
OFIX · XBRL financial data

Orthofix Medical financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (OFIX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers184,006200,415*188,608198,620196,606215,657*193,646203,121205,634219,911*196,708210,933
Cost of goods and services sold64,24363,785*61,36663,87161,55366,816*72,02763,58857,11163,569*57,16261,226
Gross profit119,763136,630*127,242134,749135,053148,841*121,619139,533148,523156,342*139,546149,707
Research and development18,55918,941*19,49218,04917,29418,808*19,76615,93414,77415,373*15,32015,944
Selling, general and administrative—year only131,691134,218130,137136,479*132,981136,493148,102136,753*134,911138,030
General and administrative27,13634,535*31,64833,99433,561———————
Total operating expenses9,549——11,23410,886———————
Operating income (loss)(24,449)(18,315)*(29,337)(24,906)(18,899)(11,477)*(48,873)(16,003)(17,046)494*(14,436)(8,134)
Other income (expense)(2,360)766*(1,274)(2,510)(2,528)(3,313)*1,2465,730(535)1,665*(734)(778)
Income tax expense (benefit)472125*8511,084751(564)*961(142)53330*74801
Net income (loss)(28,857)(22,174)*(36,020)(33,443)(27,388)(29,146)*(53,094)(14,081)(22,795)(2,222)*(20,908)(15,798)
Earnings per share, basic USD per share(0.77)—(0.95)(0.88)(0.71)—(1.35)(0.36)(0.57)(0.06)*(0.52)(0.39)
Earnings per share, diluted USD per share(0.77)—(0.95)(0.88)(0.71)—(1.35)(0.36)(0.57)(0.06)*(0.52)(0.39)
Weighted average shares, basic thousands of shares37—383838,488—39,18839,50139,76639,944*40,45040,906
Weighted average shares, diluted thousands of shares37—383838,488—39,18839,50139,76639,944*40,45040,906

Balance sheet

CSV

Fiscal quarters (OFIX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents33,66333,10726,96426,36630,05483,23857,95365,60662,86082,025120,278103,810
Accounts receivable114,118128,098125,617125,361124,845134,713131,865129,556130,808135,746137,775135,818
Inventory221,745222,166219,076210,040205,812189,452174,480172,993174,042172,319177,818184,475
Prepaid and other current assets24,17032,42224,82121,79823,00323,38223,51224,59223,37423,66725,05721,434
Total current assets393,696420,443398,978386,065386,214433,285390,310395,830394,170416,847461,520446,132
Property and equipment, net152,689159,060158,132154,111146,685139,804130,693129,200130,017129,399125,327130,757
Right-of-use asset19,76519,86919,11618,57918,05617,23816,59524,85923,96122,27921,57120,918
Goodwill194,767194,934194,934194,934194,934194,934194,934194,934194,934194,934194,934194,934
Total assets905,652925,315906,050881,998867,872893,294823,144837,157832,610850,647886,601873,020
Accounts payable53,26158,35757,14750,36247,06048,80345,17645,09850,45958,39254,68663,531
Accrued liabilities—12,189———11,391———9,857——
Current portion of long-term debt—1,2503,1254,6886,2500———0——
Total current liabilities152,530165,223150,621155,967161,898168,628144,116148,381159,847170,482161,033157,010
Long-term debt70,00093,107115,071113,315112,215157,015156,885157,047157,219157,391221,335221,591
Lease liability, non-current17,17117,12516,37215,71015,00614,08413,26626,39826,05425,41324,76024,220
Total liabilities290,169326,585335,735335,994341,948390,170364,850378,810390,124400,610451,415443,840
Accumulated deficit(127,970)(150,144)(186,164)(219,607)(246,995)(276,141)(329,235)(343,316)(366,111)(368,333)(389,241)(405,039)
Total stockholders' equity615,483598,730570,315546,004525,924503,124458,294458,347442,486450,037435,186429,180
Total liabilities and equity905,652925,315906,050881,998867,872893,294823,144837,157832,610850,647886,601873,020
Common shares outstanding (cover page) thousands of shares36,75737,40737,52938,17538,21439,02239,18139,49439,60040,14440,42240,733

Cash flows

CSV

Fiscal quarters (OFIX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(28,857)(22,174)*(36,020)(33,443)(27,388)(29,146)*(53,094)(14,081)(22,795)(2,222)*(20,908)(15,798)
Stock-based compensation6,274*3,167*8,8009,959*6,531*7,165*6,4697,824*7,181*7,214*6,5337,735*
Depreciation and amortization13,09713,969*14,86214,03215,17315,994*34,43116,87112,94113,078*13,49313,273
Net cash from operating activities477*(6,694)*(18,595)8,984*11,671*23,730*(18,391)11,639*12,402*27,697*(17,610)(6,224)*
Purchases of property and equipment21,872*14,561*10,5439,344*5,322*———————
Net cash from investing activities(22,343)*(15,053)*(10,867)(9,716)*(5,862)*(1,135)*(6,736)(7,097)*(9,894)*(10,871)*(10,515)(12,647)*
Proceeds from issuing common stock0*2,750*——120*2,946*493,005*36*2,839*——
Net cash from financing activities18,251*25,280*21,453225*(2,456)*31,487*(651)2,640*(5,152)*2,377*63,9702,451*
Net change in cash(3,944)*4,094*(8,293)(598)*3,688*53,184*(25,285)8,236*(2,743)*19,169*35,755(16,465)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
Orthofix Medical103,810210,933(6,224)*40.7M16.7 quarters 10-QJun 30, 2026
Angiodynamics33,97380,915(15,330)42.1M2.2 quarters 10-QAug 31, 2026
Axogen328,88875,83416,536*59.7M— 10-QSep 30, 2026
Delcath Systems47,52129,1335,712*34.7M— 10-QJun 30, 2026
Ceribell32,66328,097(12,863)*38.4M10.0 quarters 10-QJun 30, 2026
Iradimed63,28824,2036,997*12.8M— 10-QSep 30, 2026
Pulse Biosciences101,620434(18,709)*71.3M5.4 quarters 10-QJun 30, 2026
Butterfly Network122,30132,598(2,266)*not reported10.3 quarters 10-QSep 30, 2026
Orthopediatrics17,14172,6614,506*26.1M— 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.